Showing results (231-240 of 262) with videos related to
Sort By:
Pageof 27
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot studyM Kunz, M Urosevic-Maiwald, S M Goldinger, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)K Spieth, R Kaufmann, R Dummer, et al.Frontiers in Oncology|December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitorsH S Gabryś, L Basler, S Burgermeister, et al.Nature Medicine|October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trialR Dummer, D E Gyorki, J Hyngstrom, et al.The British Journal of Dermatology|September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trialE Stockfleth, G F L Hofbauer, U Reinhold, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)R von Moos, B Seifert, M Simcock, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2021
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trialR A Cowan, J J Scarisbrick, P L Zinzani, et al.ESMO Open|May 26, 2026
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02CM Tetzlaff, J M Taube, G V Long, et al.Journal of Cancer Research and Clinical Oncology|June 16, 2017
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumabC Brüggemann, M C Kirchberger, S M Goldinger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patientsU Keilholz, C Conradt, S S Legha, et al.Pageof 27